A new pagurid hermit crab species is assigned to the genus Kumepagurus Komai Osawa, 2012, previously represented only by the type species, K. cavernicolus Komai Osawa, 2012, known only from a marine cave on Ryukyu Islands, northwestern Pacific. The assignment is made because of the lack of an accessory tooth on the maxilliped 3 ischium, the operculiform right chela, the presence of two distal corneous claws on the left chela fixed finger, the simple pereopods 4 and the development and structure of the male sexual tubes on both coxae of pereopods 5, all characteristic to the type species of the genus. However, in contrast to K. cavernicolus, K. kaikata n. sp. lacks pleurobranchs on the thoracomeres 5 and 6, and in this regard, Kumepagurus is unusual in the family Paguridae. The generic diagnosis of Kumepagurus is emended to accommodate the new species, which is readily distinguished from K. cavernicolus by the proportionately shorter antennular and antennal peduncles and the right cheliped structure and ornamentation, in addition to the difference in the gill number.

Download full-text PDF

Source
http://dx.doi.org/10.11646/zootaxa.4858.2.5DOI Listing

Publication Analysis

Top Keywords

osawa 2012
12
pagurid hermit
8
hermit crab
8
assigned genus
8
genus kumepagurus
8
kumepagurus komai
8
komai osawa
8
type species
8
species
5
species pagurid
4

Similar Publications

Objective: This study aims to assess the surgical outcome of borderline hypoplastic left ventricle before and after the induction of the left ventricle rehabilitation strategy.

Methods: A retrospective review investigated patients with borderline hypoplastic left ventricle who underwent surgical intervention between 2012 and 2022. The patient cohort was stratified into two groups based on the initiation of left ventricle rehabilitation: an early-era group (E group, 2012-2017) and a late-era group (L group, 2018-2022).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to find early postoperative indicators that could predict complications after total cavopulmonary connection surgery, analyzing factors like pulmonary artery pressure, arterial pressure, oxygen saturation, and lactate levels.
  • A total of 249 patients, primarily young children, were evaluated, with specific postoperative measurements showing significant correlations with various complications, such as chest tube drainage and adverse events.
  • Key findings included optimal cut-off values for pulmonary artery pressures and mean arterial pressures that could help predict complications, emphasizing the importance of early monitoring in improving patient outcomes.
View Article and Find Full Text PDF

Objective: The association between knee osteoarthritis (OA) and miRNAs has been widely reported. However, the utility of miRNAs as predictors of knee osteoarthritis (KOA) progression in longitudinal studies has not been reported. We aimed to identify circulating miRNAs (c-miRNAs) associated with KOA progression in the general population and to examine their potential use as predictors of KOA progression.

View Article and Find Full Text PDF
Article Synopsis
  • A multicenter study in Japan was conducted to evaluate adverse events (AEs) related to the tag-less PillCam patency capsule (PC) used to prevent small bowel capsule endoscope (CE) retention.
  • Out of 2578 patients, 74 AEs were identified, primarily involving residual parylene coating, small bowel obstruction, and CE retention, with a 2.37% incidence rate of AEs overall.
  • The study concluded that while the PC is generally safe, careful assessment of patient history and accurate localization of the capsule are important to mitigate risks.
View Article and Find Full Text PDF

Objectives: Limited information is currently available on the efficacy and safety of axitinib for metastatic renal cell carcinoma (mRCC) patients with renal impairment. Therefore, the present study investigated the efficacy and toxicity of axitinib in patients with chronic kidney disease.

Methods: Post-hoc analyses were performed on a Japanese multicenter cohort study of 477 mRCC patients who received axitinib followed by 1 or 2 regimens of systemic antiangiogenic therapy between January 2012 and December 2016.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!